#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myeloproliferative neoplasm Gastrointestinal neuroendocrine tumour Renal cell carcinoma Superficial vein thrombosis Pyruvate dehydrogenase complex deficiency Malignant oligodendroglioma Mitochondrial myopathy Neuroendocrine carcinoma Peripheral primitive neuroectodermal tumour of soft tissue Thrombotic thrombocytopenic purpura Crohn's disease Gastric cancer Cryoglobulinaemia Anaemia Adenoid cystic carcinoma More trials…

    Learn about Rare Diseases

    Small intestine leiomyosarcoma – Life with Disease Methylmalonic acidaemia – Basic Information Glomerulonephritis membranoproliferative – Treatment Glomerulonephritis rapidly progressive – Basic Information Factor VIII deficiency – Treatment Rett syndrome – Life with Disease Hereditary hypophosphataemic rickets – Trials in Disease Mantle cell lymphoma stage II – Diagnostics Leukoencephalopathy – Treatment Netherton’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bendamustine Zinc Acexamate Fludarabine Phosphate MZE829 Iron Sucrose Norucholic Acid Donidalorsen [89ZR]ZR-DFO-CIT-013 Fadraciclib Quavonlimab CILOSTAZOL Chlorhexidine Dihydrochloride Azenosertib Tacrolimus 177Lu-Dpi-4452 Hmb-001 Astegolimab LIGUFALIMAB Img-007 Inupadenant Hydrochloride More therapies…

    Learn about Your Condition

    Dizziness Diabetic ketoacidosis Endotracheal intubation Malignant melanoma stage III Endometrial cancer stage I Type 1 diabetes mellitus Lymphoedema Hepatic cirrhosis Left ventricular failure Type 2 diabetes mellitus Influenza Hodgkin's disease recurrent Prinzmetal angina Escherichia infection Pseudomyxoma peritonei More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Ferric Derisomaltose on Cognitive Function in Heart Failure Patients with Iron Deficiency

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cognitive disorder
    • Cardiac failure
    Investigated Drugs:
    • Ferric Derisomaltose
    • Sodium Chloride
    Germany

  • Study of 18F-FAPI-74 PET/CT Imaging for Detection of Lymph Node Metastases in Patients with Colon Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    Finland

  • Study of Sacituzumab and Zimberelimab for Patients with Resectable Non-Small Cell Lung Cancer After Surgery Without Complete Disease Clearance

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Sacituzumab Govitecan
    • Zimberelimab
    Spain

  • Study on Atrasentan for Patients with IgA Nephropathy at Risk of Kidney Function Loss

    Recruiting

    3 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Atrasentan Hydrochloride
    • ZIGAKIBART
    France Germany Italy Poland Portugal Spain

  • Study Comparing Azathioprine and Methotrexate with Adalimumab for Patients with Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Adalimumab
    • Azathioprine
    • Methotrexate
    France

  • Study on Anti-CD19 CAR T-Cell Therapy for Patients with Refractory Systemic Autoimmune Diseases Using Levetiracetam, Fludarabine, and a Drug Combination

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Autoimmune disorder
    Investigated Drugs:
    • Autologous T-Cells Transduced With Lentiviral Vector Expressing A Chimeric Antigen Receptor Directed Against Cd19
    • Levetiracetam
    • Cyclophosphamide
    Italy
Previous Page
1 … 345 346 347 348 349 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!